Safar D, Aimé C, Cohen-Kaminsky S, Berrih-Aknin S
CNRS UA-1159, Hôpital Marie Lannelongue, Le Plessis-Robinson, France.
J Neuroimmunol. 1991 Dec;35(1-3):101-10. doi: 10.1016/0165-5728(91)90165-4.
The presence of anti-thymus antibodies was investigated in the serum of 36 patients with myasthenia gravis (MG). Using an immunofluorescence technique on frozen thymic sections, we found 45% of patients sera reacting with normal or MG thymuses. Staining was confined to subcapsular and medullary keratin-positive epithelial cells. Thirty-five out of 36 sera from healthy controls and all 15 sera from patients presenting another autoimmune disorder were negative. Antibodies to thymic epithelial cells were almost exclusively detected in patients presenting thymic hyperplasia and did not disappear after thymectomy. They were not clearly associated with antiacetylcholine receptor antibody titer, nor with disease severity. Their strong association to thymic abnormalities highlights the role of the thymus in pathogenesis of MG. The reasons for the appearance of these antibodies, the structure they recognize on thymic epithelial cells and their possible etiological role are discussed.
在36例重症肌无力(MG)患者的血清中检测抗胸腺抗体。运用免疫荧光技术对冰冻胸腺切片进行检测,我们发现45%的患者血清与正常或MG胸腺发生反应。染色局限于被膜下和髓质角蛋白阳性上皮细胞。36份健康对照血清中的35份以及所有15份患有其他自身免疫性疾病患者的血清均为阴性。胸腺上皮细胞抗体几乎仅在胸腺增生的患者中检测到,胸腺切除术后也未消失。它们与抗乙酰胆碱受体抗体滴度以及疾病严重程度均无明显关联。它们与胸腺异常的强烈关联突出了胸腺在MG发病机制中的作用。文中讨论了这些抗体出现的原因、它们在胸腺上皮细胞上识别的结构及其可能的病因学作用。